MaxCyte Stock (NASDAQ: MXCT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.000 / 673.830K |
Day Range | - - - |
52 Wk Range | 2.450 - 5.545 |
Market Cap | $449.836M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 3.09% |
Days to Cover | 5.12 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of MaxCyte (NASDAQ: MXCT) through any online brokerage.
Other companies in MaxCyte’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Quanterix (NASDAQ:QTRX).
The latest price target for MaxCyte (NASDAQ: MXCT) was reported by Stephens & Co. on Wednesday, March 13, 2024. The analyst firm set a price target for 11.00 expecting MXCT to rise to within 12 months (a possible 154.63% upside). 4 analyst firms have reported ratings in the last year.
The stock price for MaxCyte (NASDAQ: MXCT) is $4.32 last updated March 27, 2024 at 4:00 PM EDT.
There are no upcoming dividends for MaxCyte.
MaxCyte’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for MaxCyte.
MaxCyte is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.